Natixis Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $504K | Buy |
|
|||||
|
2024
Q4 | $433K | Sell |
|
|||||
|
2024
Q3 | $773K | Sell |
|
|||||
|
2024
Q2 | $8.37M | Buy |
|
|||||
|
2024
Q1 | $3.25M | Buy |
|
|||||
|
2023
Q4 | $2.45M | Buy |
|
|||||
|
2023
Q3 | $2.06M | Buy |
|
|||||
|
2023
Q2 | $2.02M | Sell |
|
|||||
|
2023
Q1 | $4.5M | Buy |
|
|||||
|
2022
Q4 | $5.16M | Buy |
|
|||||
|
2022
Q3 | $3.01M | Buy |
|
|||||
|
2022
Q2 | $1.69M | Sell |
|
|||||
|
2022
Q1 | $2.31M | Buy |
|
|||||
|
2021
Q4 | $2.61M | Sell |
|
|||||
|
2021
Q3 | $29.8M | Sell |
|
|||||
|
2021
Q2 | $52.5M | Buy |
|